tirosint-sol Drug Patent Profile
✉ Email this page to a colleague
When do Tirosint-sol patents expire, and what generic alternatives are available?
Tirosint-sol is a drug marketed by Ibsa and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-one patent family members in thirteen countries.
The generic ingredient in TIROSINT-SOL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tirosint-sol
A generic version of tirosint-sol was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for tirosint-sol
International Patents: | 21 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Clinical Trials: | 7 |
Patent Applications: | 3,229 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for tirosint-sol |
DailyMed Link: | tirosint-sol at DailyMed |
Recent Clinical Trials for tirosint-sol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cromsource | Phase 4 |
University of California, Los Angeles | Phase 4 |
Children's Mercy Hospital Kansas City | Phase 4 |
Pharmacology for tirosint-sol
Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for tirosint-sol
Paragraph IV (Patent) Challenges for TIROSINT-SOL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TIROSINT-SOL | Oral Solution | levothyroxine sodium | 13 mcg/mL 25 mcg/mL 50 mcg/mL 75 mcg/mL 88 mcg/mL 100 mcg/mL 112 mcg/mL 125 mcg/mL 137 mcg/mL 150 mcg/mL 175 mcg/mL 200 mcg/mL | 206977 | 1 | 2022-09-30 |
US Patents and Regulatory Information for tirosint-sol
tirosint-sol is protected by four US patents.
Patents protecting tirosint-sol
High-stability packaged solutions of T4 thyroid hormone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
High-stability packaged solutions of T4 thyroid hormone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Administration regimen of compositions of T4 thyroid hormone with high oral absorption
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF HYPOTHYROIDISM BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST
Administration regimen of compositions of T4 thyroid hormone with high oral absorption
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PITUITARY THYROTROPIN SUPPRESSION BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST
International Patents for tirosint-sol
See the table below for patents covering tirosint-sol around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3930703 | RÉGIME D'ADMINISTRATION DE SOLUTIONS D'HORMONE THYROÏDIENNE T4 À ABSORPTION ORALE ÉLEVÉE (ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION) | ⤷ Try a Trial |
Morocco | 55071 | RÉGIME D'ADMINISTRATION DE SOLUTIONS D'HORMONE THYROÏDIENNE T4 À ABSORPTION ORALE ÉLEVÉE | ⤷ Try a Trial |
China | 109789213 | T4甲状腺激素的高稳定性包装解决方案 (HIGH-STABILITY PACKAGED SOLUTIONS OF T4 THYROID HORMONE) | ⤷ Try a Trial |
Spain | 2824787 | ⤷ Try a Trial | |
Poland | 3528847 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2020178074 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |